Ibuprofen (IBU) and ketoprofen (KET) are among the world’s most popular and widely used nonsteroidal anti-inflammatory drugs (NSAIDs). Due to their high usage, these drugs have entered the environment, including the soil, and, like any other chemical compound, can have a negative effect on it. Therefore, an attempt was made to evaluate the effects of these two popular drugs on soil bacteria and fungi, the bivalve crustaceans (Heterocipris incongruens) and the growth and development of spring barley. The tested drugs did not show any negative effects on the total bacterial abundance. Effects were observed on the growth and survival of H. incongruens and on the abundance of fungi in the soil at the highest concentrations tested. The presence of IBU and KET in the soil in which spring barley was cultivated caused an increase in the activity of antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), and guaiacol peroxidase (POD); an increase in the content of proline and ascorbic acid (AsA) in the seedlings of this grain; and a decrease in the yield of fresh plant weight, especially at the application of concentrations of 100 and 1000 mg·kg⁻¹ of soil’s dry weight (DW). Effects on barley seed germination potential and germination capacity, plant dry matter content, assimilation pigment content and malondialdehyde (MDA) were also observed at the highest concentrations.

Ampicillin (AMP) and amoxicillin (AMX) are popular antibiotics, which are penicillin derivatives, and are used in both human and veterinary medicine. In the conducted study, AMP, AMX and their mixtures did not cause major changes in the total bacterial counts in soil samples, and even an increase in the bacterial counts from 3,700,000 to 6,260,000 colony-forming units (cfu) per gram of soil dry weight (g of soil DW) was observed for minimal amounts of these drugs in the soil. The total abundance of fungi, on the other hand, increased from values ranging from 17,000 to 148,000 cfu∙g⁻¹ of soil DW to a level of 32,000 to 131,000 cfu∙g⁻¹ of soil DW. The tested antibiotics and their mixtures had no significant effect on the mortality and growth of H. incongruens. AMX and the AMP + AMX mixture also showed no effect on the plant fresh weight yield, plant aboveground part length and dry weight content of wheat seedlings. In contrast, AMP caused an increase in the plant fresh weight yield and wheat seedling length compared to the control. The drug also caused a slight decrease in the seedling dry weight content. Both AMP and AMX showed inhibitory effects on the plant root length at the highest concentrations of the compounds.

Ampicillin (AMP) and amoxicillin (AMX) are widely used penicillin antibiotics. After administration to humans and animals, they are largely excreted in unchanged or metabolized forms, leading to their release into wastewater. In surface waters, their concentrations usually reach the ng∙L⁻¹ range and rarely exceed µg∙L⁻¹, although in India AMX levels above mg∙L⁻¹ were detected in hospital effluents. The limited efficiency of wastewater treatment plants allows these compounds to enter aquatic and terrestrial environments, where they affect various organisms. The aim of this study was to assess the effects of AMP, AMX, and their mixture on wheat, one of the most extensively cultivated cereals. Determinations were carried out using standardized methodologies. The results showed that antibiotics induce oxidative stress in plants, with symptoms observed only at concentrations of 1000 mg∙kg⁻¹ of soil DW. At this level, changes included altered antioxidant enzyme activity (APX, SOD, POD, and CAT), increased proline and H₂O₂ content, and reduced MDA levels. By contrast, antibiotics had minimal influence on glutathione and ascorbate and caused only slight changes in photosynthetic pigments and chlorophyll fluorescence.

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis remain incurable. Current therapeutic strategies primarily focus on slowing disease progression, alleviating symptoms, and improving patients’ quality of life, including the management of comorbid conditions. Over the past few decades, the incidence of diagnosed neurodegenerative disorders has risen significantly. As the number of affected individuals continues to grow, so does the urgent need for effective treatments that can halt or mitigate the progression of these diseases. Among the most promising therapeutic resources are bioactive compounds derived from fungi. The high quality of proteins, polysaccharides, unsaturated fatty acids, triterpenoids, sterols, and secondary metabolites found in fungi have attracted growing interest from researchers across multiple disciplines. One intensively studied direction involves the use of naturally occurring fungi-derived nutraceuticals in the treatment of various diseases, including neurodegenerative conditions. This article provides an overview of recent findings on fungal compounds—such as phenolic compounds, carbohydrates, peptides and proteins, and lipids—that may have potential applications in the treatment of neurodegenerative diseases and the alleviation of their symptoms.